NCT05735158View on ClinicalTrials.gov

Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

PHASE2UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

April 30, 2024

Conditions
Autosomal Recessive Ichthyosis
Interventions
BIOLOGICAL

KB105

Replication-defective, non-integrating HSV-1 vector expressing TGM1 formulated as a topical gel

OTHER

Placebo

Visually matched excipient gel

Trial Locations (1)

92688

Mission Dermatology, Rancho Santa Margarita

Sponsors
All Listed Sponsors
lead

Krystal Biotech, Inc.

INDUSTRY

NCT05735158 - Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) | Biotech Hunter | Biotech Hunter